Mualliflar

  • Азизбек Холмирзаевич Жахонов
  • Аълонур Бахтинурович Саидов
  • Дилфуза Сабуровна Маткаримова
  • Кодиржон Тухтабоевич Бобоев

##semicolon##

IL17A (G-197A), аутоиммунная гемолитическая анемия, аллель, генотип, риск развития.

##submission.citations##

AlFadhli S., AlFailakawi A., Ghanem A. A. M. Th‐17 related regulatory network in the pathogenesis of Arab patients with systemic lupus erythematosus and lupus nephritis //International Journal of Rheumatic Diseases. – 2016. – Т. 19. – №. 5. – С. 512-520.

Barcellini W , Giannotta J , Fattizzo B . Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Rev Hematol 2020; 13:585–97 doi:10.1080/17474086.2020 .17 54791.

Barcellini W. et al. New insights in autoimmune hemolytic anemia: from pathogenesis to therapy //Journal of clinical medicine. – 2020. – Т. 9. – №. 12. – С. 3859.

Barcellini W., Fattizzo B. The changing landscape of autoimmune hemolytic anemia //Frontiers in immunology. – 2020. – Т. 11. – С. 946.

Berentsen S., Barcellini W. Autoimmune hemolytic anemias //New England Journal of Medicine. – 2021. – Т. 385. – №. 15. – С. 1407-1419.

Branch D. R. et al. The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia //Blood Advances. – 2023. – Т. 7. – №. 10. – С. 2166-2170.

Devasia A. J. et al. NUDT15 polymorphism explains serious toxicity to azathioprine in Indian patients with chronic immune thrombocytopenia and autoimmune hemolytic anemia: a case series //Drug Metabolism and Personalized Therapy. – 2020. – Т. 35. – №. 4. – С. 20200128.

El-Edel R. et al. Inosine triphosphate pyro-phosphatase gene polymorphisms and ribavirin-in-duced Anemia in HCV patients //J Mol Biomark Diagn. – 2017. – Т. 8. – №. 360. – С. 2.

Han-You M. et al. Response to:‘Correspondence on ‘Increased risk of systemic lupus ery-thematosus in patients with autoimmune haemolytic anaemia: a nationwide population-based cohort study’’by Goulielmos and Zervou //Annals of the Rheumatic Diseases. – 2023. – Т. 82. – №. 1. – С. e20-e20.

Weinacht K. G. et al. Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation //Journal of Allergy and Clinical Immunology. – 2017. – Т. 139. – №. 5. – С. 1629-1640.

Zheng L, Yangsheng Y Y , et al . Genetic alleles associated with SLE susceptibility and clinical manifestations in Hispanic patients from the Domin-ican Republic. Curr Mol Med 2019;19:164–71.